REPLICEL LIFE SCIENCES INC (RP.CA) Stock Price & Overview
TSX-V:RP • CA76027P4006
Current stock price
The current stock price of RP.CA is 0.015 CAD. Today RP.CA is up by 50%. In the past month the price increased by 50%. In the past year, price decreased by -90%.
RP.CA Key Statistics
- Market Cap
- 124.5K
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- N/A
- Dividend Yield
- N/A
RP.CA Stock Performance
RP.CA Stock Chart
RP.CA Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to RP.CA. When comparing the yearly performance of all stocks, RP.CA is a bad performer in the overall market: 98.08% of all stocks are doing better.
RP.CA Earnings
RP.CA Forecast & Estimates
RP.CA Groups
Sector & Classification
RP.CA Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
RP.CA Ownership
RP.CA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ARCH | ARCH BIOPARTNERS INC | N/A | 32.267M | ||
| IOT | INNOVOTECH INC | N/A | 10.344M |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the TSX Venture Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
About RP.CA
Company Profile
RepliCel Life Sciences, Inc. is a regenerative medicine company, which engages in developing cell therapies for aesthetic and orthopedic conditions. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2012-09-29. The firm is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product consists of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. The firm has also developed a proprietary injection device (DermaPrecise) and related consumables, which is expected to improve the administration of its cell therapy products and certain other injectables. DermaPrecise is a dermal injector and motorized injection device with programmable depth and volume, a built-in Peltier element for pre-injection numbing of the skin and interchangeable needle head configurations.
Company Info
IPO: 2012-09-29
REPLICEL LIFE SCIENCES INC
570 Granville St Suite 900
Vancouver BRITISH COLUMBIA V6C 3P1 CA
CEO: R. Lee Buckler
Employees: 1
Phone: 16042488693
REPLICEL LIFE SCIENCES INC / RP.CA FAQ
What does REPLICEL LIFE SCIENCES INC do?
RepliCel Life Sciences, Inc. is a regenerative medicine company, which engages in developing cell therapies for aesthetic and orthopedic conditions. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2012-09-29. The firm is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product consists of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. The firm has also developed a proprietary injection device (DermaPrecise) and related consumables, which is expected to improve the administration of its cell therapy products and certain other injectables. DermaPrecise is a dermal injector and motorized injection device with programmable depth and volume, a built-in Peltier element for pre-injection numbing of the skin and interchangeable needle head configurations.
What is the current price of RP stock?
The current stock price of RP.CA is 0.015 CAD. The price increased by 50% in the last trading session.
Does REPLICEL LIFE SCIENCES INC pay dividends?
RP.CA does not pay a dividend.
How is the ChartMill rating for REPLICEL LIFE SCIENCES INC?
RP.CA has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
What is the employee count for RP stock?
REPLICEL LIFE SCIENCES INC (RP.CA) currently has 1 employees.
What is REPLICEL LIFE SCIENCES INC worth?
REPLICEL LIFE SCIENCES INC (RP.CA) has a market capitalization of 124.50K CAD. This makes RP.CA a Nano Cap stock.